Mary MBA - Gamida Cell Principal CFO

GMDADelisted Stock  USD 1.40  0.09  6.04%   

CFO

Mary MBA is Principal CFO of Gamida Cell
Age 61
Phone972 2 659 5666
Webhttps://www.gamida-cell.com

Gamida Cell Management Efficiency

The company has return on total asset (ROA) of (0.4147) % which means that it has lost $0.4147 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.0379) %, meaning that it created substantial loss on money invested by shareholders. Gamida Cell's management efficiency ratios could be used to measure how well Gamida Cell manages its routine affairs as well as how well it operates its assets and liabilities.
Gamida Cell currently holds 82.94 M in liabilities. Gamida Cell has a current ratio of 2.52, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Gamida Cell's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 3 records

CFO Age

Marella ThorellSeres Therapeutics
57
Marella CPASeres Therapeutics
57
Adam MostafaX4 Pharmaceuticals
44
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company was founded in 1998 and is headquartered in Jerusalem, Israel. Gamida Cell operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 166 people. Gamida Cell (GMDA) is traded on NASDAQ Exchange in USA and employs 143 people.

Management Performance

Gamida Cell Leadership Team

Elected by the shareholders, the Gamida Cell's board of directors comprises two types of representatives: Gamida Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gamida. The board's role is to monitor Gamida Cell's management team and ensure that shareholders' interests are well served. Gamida Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gamida Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
Penny Bushell, Chief Officer
Tracey Lodie, Chief Scientific Officer
Joshua Patterson, General Officer
Paul Nee, VP Marketing
Vladimir Melnikov, Senior Manufacturing
Linda Stamler, Vice Management
Heather DiVecchia, Chief Staff
Naftali CPA, Senior Operations
RPh MBA, Chief Officer
Ronit MD, Chief Officer
Abigail Jenkins, CEO President
Mary MBA, Principal CFO

Gamida Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Gamida Cell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Gamida Stock

If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities